cytarabine has been researched along with Myelomonocytic Leukemia, Chronic in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (12.50) | 18.7374 |
| 1990's | 8 (33.33) | 18.2507 |
| 2000's | 8 (33.33) | 29.6817 |
| 2010's | 4 (16.67) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Bazinet, A; Borthakur, G; Chien, KS; Darbaniyan, F; Daver, NG; DiNardo, CD; Garcia-Manero, G; Hammond, D; Jabbour, EJ; Kadia, TM; Kanagal-Shamanna, R; Kantarjian, HM; Konopleva, MY; Montalban-Bravo, G; Pemmaraju, N; Pierce, SA; Ravandi, F; Sasaki, K; Venugopal, S | 1 |
| Hannon, M; Kasner, M; Nwaoduah, N; Wilde, L | 1 |
| Akasaka, T; Honjo, G; Izumi, K; Kishimori, C; Maesako, Y; Ohno, H; Okamori, S; Okumura, A; Takeoka, K | 1 |
| Prada Garcia, C; Rodriguez Prieto, MÁ; Sanchez Sambucety, P | 1 |
| Carrascosa, JM; Ferrándiz, C; Guinovart, RM | 1 |
| Ahn, HS; Choi, HS; Kang, HJ; Shin, HY | 1 |
| Diehl, V; Hoffmann, M; Seiberlich, B; Staib, P; Tesch, H; Weihrauch, MR | 1 |
| Boula, AM; Christoforidou, AV; Foudoulakis, AM; Mantadakis, E; Samonis, G; Xilouri, IM | 1 |
| Bouabdallah, K; Daskalakis, M; Johansson, B; Kunzmann, R; Lübbert, M; Mauritzson, N; Müller-Berndorff, H; Onida, F; Schmitt-Gräff, A | 1 |
| Aguilera Cros, C; Gómez, JP; Gutierrez, I | 1 |
| Brianzoni, F; Centurioni, R; Ciniero, L; Danieli, G; Leoni, P; Montillo, M; Offidani, M; Olivieri, A; Salvi, A; Ziarati, H | 1 |
| Cosson, A; Fenaux, P; Grardel, N; Lepelley, P; Poulain, S; Preudhomme, C | 1 |
| Andreeff, M; Beran, M; Cortes, J; Estey, E; Giles, FJ; Hayes, K; Kantarjian, H; Keating, M; Koller, CA; Kornblau, S; O'Brien, S; Pierce, SR; Vey, N; Wong, GC | 1 |
| Beran, M; Kantarjian, H | 1 |
| Hu, ZB; McCulloch, EA; Minden, MD; Stahl, J | 1 |
| Kaya, H; Maeno, K; Matsuda, T; Nakamura, S; Ohtake, S; Okafuji, K; Tanaka, N; Terasaki, Y | 1 |
| Bennett, JM; Dewald, GW; Friedenberg, WR; Hayes, FA; Hiddemann, W; Lazarus, HM; Liesveld, JL; Marsh, RD; Miller, KB; Paietta, E; Rowe, JM; Saba, HT; Young, MS | 1 |
| Carbone, TV; Kelleher, JF | 1 |
| Bauters, F; Fenaux, P; Jouet, JP; Lai, JL; Morel, P; Rose, C | 1 |
| Biliczki, F; Bozóky, G | 1 |
| Derigs, G; Heyll, A | 1 |
| Chiba, S; Kikuchi, M; Misago, M; Mori, N; Nagata, K; Nakata, K; Oda, S; Otani, H; Sato, T; Tsukada, J | 1 |
| Horiike, S; Horiuchi, H; Iwamoto, K; Kitani, K; Kobayashi, Y; Kondo, M; Maruo, N; Misawa, S; Mizuno, T; Ozawa, M | 1 |
| Dohy, H; Kyo, T | 1 |
3 review(s) available for cytarabine and Myelomonocytic Leukemia, Chronic
| Article | Year |
|---|---|
[Differentiating agents in myelodysplastic syndromes. Analysis of personal cases].
Topics: Aged; Anemia, Myelophthisic; Anemia, Refractory, with Excess of Blasts; Colony-Stimulating Factors; Cytarabine; Female; Humans; Leukemia, Myelomonocytic, Acute; Leukemia, Myelomonocytic, Chronic; Macrophage Colony-Stimulating Factor; Male; Middle Aged; Myelodysplastic Syndromes | 1993 |
Monosomy 7 syndrome in an infant with neurofibromatosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chromosomes, Human, Pair 7; Combined Modality Therapy; Cytarabine; Daunorubicin; Dexamethasone; Diagnosis, Differential; Etoposide; Humans; Infant; Leukemia, Myelomonocytic, Chronic; Male; Monocytes; Monosomy; Neurofibromatosis 1; Pedigree; Preleukemia; Syndrome; Thioguanine | 1991 |
[Therapeutic possibilities in the treatment of the myelodysplasia syndrome].
Topics: Age Factors; Anemia, Sideroblastic; Antineoplastic Agents; Blastomeres; Bone Marrow Transplantation; Cytarabine; Hematopoiesis; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes | 1991 |
6 trial(s) available for cytarabine and Myelomonocytic Leukemia, Chronic
| Article | Year |
|---|---|
Novel regimen for the treatment of juvenile myelomonocytic leukemia (JMML).
Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Infant; Isotretinoin; Leukemia, Myelomonocytic, Chronic; Male; Salvage Therapy; Survival Rate; Treatment Outcome; Vincristine | 2004 |
Phase I/II clinical study of topotecan and cytarabine in patients with myelodysplastic syndrome, chronic myelomonocytic leukemia and acute myeloid leukemia.
Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Cytarabine; Disease-Free Survival; Female; Hemoglobinometry; Humans; Leukemia, Myeloid; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Myelodysplastic Syndromes; Remission Induction; Survival Analysis; Topotecan; Treatment Outcome | 2004 |
Expression of lung resistance protein and correlation with other drug resistance proteins and outcome in myelodysplastic syndromes.
Topics: Acute Disease; Antibiotics, Antineoplastic; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytarabine; Danazol; Disease Progression; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation; Hematopoietic Stem Cells; Humans; Karyotyping; Leukemia, Myeloid; Leukemia, Myelomonocytic, Chronic; Life Tables; Myelodysplastic Syndromes; Neoplasm Proteins; Proto-Oncogene Proteins c-bcl-2; Quinine; Survival Analysis; Treatment Outcome; Tumor Suppressor Protein p53; Vault Ribonucleoprotein Particles | 1998 |
Topotecan and cytarabine is an active combination regimen in myelodysplastic syndromes and chronic myelomonocytic leukemia.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Prognosis; Remission Induction; Topotecan | 1999 |
Results of topotecan-based combination therapy in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Karyotyping; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Platelet Count; Remission Induction; Risk Assessment; Survival Rate; Thrombocytopenia; Topotecan | 1999 |
Phase II study of combination human recombinant GM-CSF with intermediate-dose cytarabine and mitoxantrone chemotherapy in patients with high-risk myelodysplastic syndromes (RAEB, RAEBT, and CMML): an Eastern Cooperative Oncology Group Study.
Topics: Aged; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Chemical and Drug Induced Liver Injury; Cytarabine; DNA Replication; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hyperbilirubinemia; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Mitoxantrone; Myelodysplastic Syndromes; Pancytopenia; Pilot Projects; Recombinant Proteins; Remission Induction; S Phase; Treatment Failure | 2001 |
15 other study(ies) available for cytarabine and Myelomonocytic Leukemia, Chronic
| Article | Year |
|---|---|
A retrospective study of cladribine and low-dose cytarabine-based regimens for the treatment of chronic myelomonocytic leukemia and secondary acute myeloid leukemia.
Topics: Cladribine; Cytarabine; Humans; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Prospective Studies; Retrospective Studies | 2023 |
Chronic myelomonocytic leukemia with central nervous system involvement.
Topics: Antimetabolites, Antineoplastic; Central Nervous System; Cytarabine; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myelomonocytic, Chronic; Leukocytosis; Male; Methotrexate; Middle Aged; Monocytes; Treatment Outcome | 2018 |
inv(2)(p23q13)/RAN-binding protein 2 (RANBP2)-ALK fusion gene in myeloid leukemia that developed in an elderly woman.
Topics: Aged; Anaplastic Lymphoma Kinase; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Chromosome Inversion; Chromosomes, Human, Pair 2; Cytarabine; Daunorubicin; Diagnosis, Differential; Female; Humans; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Molecular Chaperones; Nuclear Pore Complex Proteins; Oncogene Proteins, Fusion; Receptor Protein-Tyrosine Kinases; Treatment Outcome | 2014 |
[Cutaneous infiltratiton by chronic myelononocytic leukemia: presentation of three cases].
Topics: Aged; Antineoplastic Agents; Azacitidine; Cytarabine; Fatal Outcome; Humans; Hydroxyurea; Leukemia, Myelomonocytic, Chronic; Leukemic Infiltration; Male; Skin | 2013 |
[Leukemia cutis arising at the site of injection of a tetanus vaccine booster].
Topics: Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Etoposide; Fatal Outcome; Humans; Idarubicin; Immunization, Secondary; Leukemia, Myelomonocytic, Chronic; Leukemic Infiltration; Leukosialin; Male; Middle Aged; Radiotherapy, Adjuvant; Shock, Septic; Skin; Tetanus Toxoid | 2010 |
Veno-occlusive disease of the liver associated with chronic myelomonocytic leukemia treated with vincristine and standard doses of cytarabine.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease Progression; Fatal Outcome; Hepatic Veno-Occlusive Disease; Humans; Hypoalbuminemia; Leukemia, Myelomonocytic, Chronic; Male; Paresis; Renal Insufficiency; Thrombocytopenia; Vincristine | 2005 |
Trisomy 19 as the sole chromosomal abnormality in proliferative chronic myelomonocytic leukemia.
Topics: Aged; Azacitidine; Chromosome Aberrations; Chromosomes, Human, Pair 19; Cytarabine; Cytogenetic Analysis; Daunorubicin; Decitabine; Dose-Response Relationship, Drug; Fatal Outcome; Female; Humans; Hydroxyurea; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Myelodysplastic Syndromes; Phenotype; Steroids; Treatment Outcome | 2006 |
Leukemic infiltration of the knee.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Fatal Outcome; Humans; Hydroxyurea; Knee; Leukemia, Myelomonocytic, Chronic; Leukemic Infiltration; Magnetic Resonance Imaging; Male; Prednisolone | 2006 |
Regulation of drug sensitivity by ribosomal protein S3a.
Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line; Cryopreservation; Cytarabine; DNA Replication; DNA, Neoplasm; Doxorubicin; Drug Resistance, Neoplasm; Gene Targeting; Humans; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Neoplasm Proteins; Neoplastic Stem Cells; Paclitaxel; Phosphorylation; Phosphoserine; Protein Processing, Post-Translational; Rats; Ribosomal Proteins; Tissue Preservation; Treatment Outcome; Tretinoin | 2000 |
Trisomy 14 with thrombocytosis and monocytosis.
Topics: Aclarubicin; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Chromosomes, Human, Pair 14; Cytarabine; Humans; Hydroxyurea; Leukemia, Myelomonocytic, Chronic; Leukocyte Disorders; Male; Monocytes; Quality of Life; Thrombocytosis; Trisomy | 2000 |
Prognostic factors in adult de novo myelodysplastic syndromes treated by intensive chemotherapy.
Topics: Adolescent; Adult; Aged; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Antibiotics, Antineoplastic; Cytarabine; Drug Therapy, Combination; Female; Humans; Karyotyping; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Prognosis; Remission Induction | 1991 |
Chronic myelomonocytic leukemia: clinical data, morphological features, and outcome in 56 patients.
Topics: Biomarkers, Tumor; Blast Crisis; Bone Marrow; Cytarabine; Germany, West; Hemorrhage; Humans; Leukemia; Leukemia, Myelomonocytic, Chronic; Life Tables; Prednisone; Splenomegaly; Survival Rate | 1990 |
[Successful treatment with a small dose of N4-behenoyl-1-beta-D-arabinofuranosylcytosine in a case of chronic myelomonocytic leukemia in blastic crisis].
Topics: Antineoplastic Agents; Blast Crisis; Cytarabine; Female; Humans; Leukemia, Myelomonocytic, Chronic; Middle Aged; Remission Induction | 1989 |
[Successful treatment of chronic myelomonocytic leukemia (CMMoL) with N4-palmitoyl-1-beta-D-arabinofuranosylcytosine (PLAC)].
Topics: Aged; Antineoplastic Agents; Chromosome Inversion; Chromosomes, Human, Pair 1; Cytarabine; Hematopoietic Stem Cells; Humans; Karyotyping; Leukemia, Myelomonocytic, Chronic; Male; Remission Induction | 1988 |
Results of aggressive chemotherapy for myelodysplastic syndromes.
Topics: Adult; Aged; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Male; Mercaptopurine; Middle Aged; Myelodysplastic Syndromes; Prednisolone; Remission Induction; Vincristine | 1988 |